Know Cancer

or
forgot password

A Pilot Observational Study to Determine the Prevalence of HPV Serology in HIV Seropositive Women From Subsaharan Africa and Brasil


N/A
18 Years
N/A
Not Enrolling
Female
HIV, HIV Infections

Thank you

Trial Information

A Pilot Observational Study to Determine the Prevalence of HPV Serology in HIV Seropositive Women From Subsaharan Africa and Brasil


Plasma from HIV seropositive women will be taken and sent to MERCK in the USA to evaluate
what the antibody titers of HPV 6,11,16 and 18. .


Inclusion Criteria:



- HIV seropositive women 18 years of age and older Consent signed per local IRB
requirement

Exclusion Criteria:

- Can not give blood

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

To determine the seroprevalence of HPV types 6,11,16,18 in HIV serOpositive women for Botswana, South Africa and Brazil

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Cynthia S Firnhaber, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Clinical HIV Research Unit University of Witwatersrand

Authority:

South Africa: Human Research Ethics Committee

Study ID:

Merck P0806

NCT ID:

NCT00840905

Start Date:

February 2009

Completion Date:

December 2010

Related Keywords:

  • HIV
  • HIV Infections
  • HPV
  • HIV Infections
  • Acquired Immunodeficiency Syndrome

Name

Location